Genetic Characterization of Congenital Defects in Dogs: Caudal Dysplasia, Ectodermal Dysplasia, and Mucopolysaccharidosis VII

    September 2013 in “ Helda (University of Helsinki)
    Marjo K. Hytönen
    TLDR Mutations in specific genes cause certain congenital defects in dogs, aiding in understanding similar human diseases.
    This study investigated the genetics of three inherited developmental defects in dogs: caudal dysplasia, ectodermal dysplasia, and mucopolysaccharidosis VII, which have human counterparts. For caudal dysplasia, a mutation in the T gene was linked to short-tail phenotype in 17 dog breeds, with homozygous mutations being lethal. Ectodermal dysplasia was linked to a 7-bp duplication in the FOXI3 gene, affecting hair and tooth formation. In Brazilian Terriers, mucopolysaccharidosis VII was caused by a mutation in the GUSB gene. The study highlighted the use of dogs as models for human diseases, identified new genetic pathways, and developed genetic tests for breeding purposes.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    3 / 3 results

      community Hair loss research is a money grab

      in Chat  217 upvotes 1 month ago
      Hair loss is linked to DHT, with treatments like finasteride and minoxidil being common but not definitive. Economic interests influence research, and there is potential for new treatments like PP405 and RU58841.

      community OFFICIAL Multi-Center Verteporfin Trial Recruitment

      in Research/Science  250 upvotes 6 months ago
      Recruitment for a verteporfin trial and a separate hair cloning trial using verteporfin and other methods is underway, with locations in Jordan, NYC, Beverly Hills, and Memphis. Dr. Bloxham is conducting the hair cloning trial, and interested participants are encouraged to contact him directly.

      community Verteporfin and Microneedling

      in Treatments 1 year ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

    Similar Research

    5 / 1000+ results